Itonis, Inc. (ITNS)

0.0006 0.0000 (0.00%) At close: 03:54PM EDT

Itonis, Inc.

22951 Mill Creek Drive
Suite A-1
Laguna Hills, CA 92653
United States
949-200-8887
https://www.itonisholdings.com

Sector(s): Healthcare
Industry: Medical Distribution
Full-time employees: 3

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Mark H. Cheung	CEO, President & Director	N/A	N/A	N/A
Dr. Donald L. Jolly	CFO & Treasurer	N/A	N/A	N/A
Mr. Corey Washington	Chief Technology Officer	N/A	N/A	N/A
Dr. Charles B. Hensley Ph.D.	President of Itonis Pharmaceuticals	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Itonis, Inc., a development stage company, focuses on producing and marketing over the counter and prescription homeopathic preparations to treat common ailments and chronic diseases. The company intends to sells its over-the-counter to alleviate mild to moderate nausea. It has placed a manufacturing order for the first batch of its Emesyl product line. The company was formerly known as Kenshou, Inc. and changed its name to Itonis, Inc. in December 2005. Itonis, Inc. was founded in 2005 and is headquartered in Laguna Hills, California.

Corporate governance

Itonis, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.